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    Ischemic mitral regurgitation is affiliated with changes in annular dimensions as well 
as remodeling of the left ventricle. Undersized mitral annuloplasty (UMA), which 
involves implanting a titanium-based ring-like structure onto the mitral annulus, is aimed 
at reducing annular dimensions in order to restore leaflet coaptation and therefor correct 
IMR. The durability of this treatment is improved with papillary muscle approximation 
(PMA), in which a suture draws together the two papillary muscles that connect the 
mitral valve to the heart muscle, reducing the lateral separation of the papillary muscles 
in order to relieve tethering on the mitral leaflets to correct IMR. The participants in this 
investigation are retrospectively identified patients who have already undergone surgery 
for IMR. The purpose of this retrospective study is to investigate (1) the impact UMA has 
on left ventricular function and (2) whether preoperative geometry, specifically inter-




















    The human heart has four valves, two on the left side and two on the right side, which 
help maintain unidirectional blood flow and efficient cardiac pumping. The mitral valve, 
located on the left side between the left atrium and left ventricle (LV), can become prone 
to leaking. This disease state, known as mitral regurgitation (MR), is a structural heart 
pathology described as the backflow of blood into the left atrium due to insufficient 
closing of the valve leaflets during systole. This condition can subsequently lead to 
dysfunction of the left ventricle, which could ultimately result in heart failure1. The 
pathology can be either primary MR due to an organic dysfunction of a portion of the 
valve itself, or secondary MR which originates from LV remodeling2.  More specifically, 
ischemic mitral regurgitation (IMR) arises from complications with left ventricular 
remodeling due to coronary artery disease or following myocardial infarction (MI), as is 
the case in approximately one-fifth of patients2,3. IMR is associated with decreased long-
term survival rates in patients post MI and is present in 10% of patients with coronary 
artery disease (CAD). Overall, 70% of congestive heart failure (CHF) cases in the U.S 
are due to cardiomyopathy (diseases of the heart muscle) and 50% of those cases involve 
patients with IMR. This totals to a range of 1.6 to 2.8 million cases of IMR in the United 
States alone4-7. The pathology of this disease state will now be discussed in greater detail.  
       IMR can be distinguished by tethering of the posterior leaflet, primary history of MI, 





In the diseased state, the mitral valve will also lose its saddle-like shape and become 
flattened. Displacement of the papillary muscles increases the tethering force on the  
leaflets, while decreased ventricular function leads to decreased closing forces, as seen in 
Figure 1. These factors interfere with systolic closing, which can lead to regurgitation. 












Figure 1: Demonstration of the effects of papillary muscle impairment and tethering as indicators of IMR 




Undersized Mitral Valve Annuloplasty  
and Papillary Muscle Approximation 
 
      As annular dilation is almost always present in patients with IMR, undersized mitral 
valve annuloplasty (UMA), a simple and reproducible procedure, is currently considered 
the gold standard of treatment. This surgical approach aims to restore native annulus 
geometry, prevent further dilation, and increase coaptation surface of the leaflets10,11. The 





valve in order to obtain a coaptation length of at least 8 mm10. A full-size ring (instead of 
a partial ring) is more common in IMR patients to help reduce the possibility of 
recurrence12,13. This procedure was first used in a study conducted by Bach et al. on a 
cohort of 9 patients. The report alludes to observing recovery of left ventricular function, 
as transformation of LV shape is a substrate for development of IMR14.The overall 
symptoms of all patients showed marked improvement (effective correction of mitral 
regurgitation confirmed by color flow Doppler imaging), but more research was needed 
in order to generalize the results to a broader population.15,16 Some of the more recent 
literature has also highlighted adverse effects of restrictive annuloplasty, such as a 
possible creation of functional mitral stenosis associated with higher pulmonary arterial 
pressure and worse functional capacity.17-19  
      
    Because excessive annular reduction by UMA can lead to mitral stenosis and worse 
functional capacity, papillary muscle approximation (PMA) has been recently suggested 
to be coupled with UMA. PMA relieves leaflet tethering by drawing together the two 
muscles that connect the mitral valve to the heart muscle, reducing inter-papillary muscle 
separation so aggressively that UMA may not be necessary for IMR correction20-23. This 
reduction in interpapillary muscle distance (IPMD) helps to restore leaflet coaptation24,25. 
The major findings of a study conducted by Nappi et al. revealed higher rates of MR 
reappearance in patients who had undergone UMA alone compare to those who had 
undergone PMA (55.9% recurrence vs. 27% respectively in a 5-year follow up period).26 
Overall, the study aims to determine the best surgical technique for treatment of IMR, as 






  If the patient is appropriately selected, UMA alone, or a combination of UMA + PMA, 
promotes reverse remodeling of the LV26 and improves overall quality of life. The best 
candidates for this procedure are in the early phases of the disease with a short history of 
heart failure, do not have an excessively dilated left ventricle, and have no 
echocardiographic evidence of potential recurrence of MR4,27,28. This study investigated 
the use of these techniques in patients with IMR in order to examine the first hypothesis 
that correction utilizing UMA improves left ventricular function.  
Preoperative Selection of Patients 
         Surgeons must preoperatively evaluate patients in order to determine the likelihood 
of a positive outcome with undersized annuloplasty. There are factors that increase a 
patient’s chances of being selected for this kind of surgical repair because of the 
inclination towards positive postoperative outcomes. For example, patients with less 
severe tethering and increased left ventricular ejection fraction (LVEF) are favored 
because they have more treatable MR and can tolerate increased cross clamp time4. Also, 
in patients with preoperative left ventricular end-diastolic diameter (LVEDD) that 
exceeds 65 mm, the five-year survival rate is significantly lower than patients with 
LVEDD of 65 mm or less (49% vs. 80% respectively)12. Additional analysis of the 
preoperative mitral valve configuration has indicated that in patients undergoing 
restrictive annuloplasty, the posterior leaflet (PL) angle (as can be seen in Figure 2) may 
be the strongest predictor of postoperative outcomes29. A PL angle of ≥45 degrees has 





Figure 2: Evaluation of the posterior leaflet angle as a 
preoperative parameter for indicating outcomes for 
undersized annuloplasty to correct IMR. Other factors 
evaluated via echocardiography included anterior 
leaflet angle, coaptation distance, and tenting area.29  
 
 
Echocardiography, Magnetic Resonance Imaging (MRI) and Strain Analysis 
   Echocardiography is the main method used to visually evaluate cardiac function, as 
well as diagnose chronic IMR7,31. Ultrasound waves create images of the heart, which can 
be translated into different views for assessing mitral valve and ventricular pathologies. 
The essential views for assessment of the mitral valve will now be discussed. The 
parasternal long axis view shows thickness of the leaflets and their motion during 
cardiac cycling. With this view, mitral valve tenting area  (the area between the annular 
line and the leaflets), coaptation distance (distance between annular line and coaptation 
point), and posterior leaflet angle (inverse sine of CD/PLL per Figure 2) can be 
measured29. Visualization of the left atrium is also available.  
    Mitral leaflet motion and their attachment to the chordae is visible in the parasternal 
short axis view. Mitral valve area can also be measured from this image. Coaptation of 
both mitral valve leaflets as well as LV diastolic parameters can be assessed via the 
apical four chamber view (as seen in Figure 3). This is of particular use for evaluating 
left ventricular function following restrictive annuloplasty. The degree of possible mitral 
regurgitation and evaluation of different segments of the leaflets is best done with the 





using the width of the vena contracta (narrowest portion of color jet) of the regurgitant jet 










Figure 3: Mitral valve in four chamber view in order to measure the annulus32. 
  
   MRI holds the standard for noninvasive measurement of ventricular size and function33. 
The accuracy of this method for calculating ventricular volumes is based on the ability to 
choose the imaging plane, eliminating the need for assumptions of geometry. 
Quantification of left and right ventricular stroke volume is done by segmenting the 
ventricles from the base to the apex of the heart in end-diastole and end-systole as seen in 
Figure 4 (basal, equatorial, and apical slices). This has important clinical applications, as 
reliable detection of changes in cardiac chamber size can be used as a guide for surgical 
intervention and timing of MV therapies34. MR can also be measured based on 
quantitative flow, as mitral regurgitant volume is calculated as the difference between left 
ventricular stroke volume (LVSV) and forward flow33. LV remodeling and reverse 














Figure 4: Segmentation of the ventricles from base to the apex in both end-diastole and end-systole35. 
     
    LV function can be quantified through the principle of myocardial strain, which 
describes local changes in myocardial thickness (as observed through MRI in this 
investigation)36,37. In the case of short axis views, strains from each LV segment can only 
be calculated along circumferential and radial directions. Left ventricular ejection 
fraction (LVEF) is the most consistent physiological predictor of adverse outcomes for 
regurgitant valvular disease cases1. In short, reduced LVEF indicates decreased 
myocardial contractility, a late consequence of the disease which can imply irreversible 
damage to the myocardium1. The current shift in clinical settings is to use strain imaging 
to identify this injury at an early stage, before reduction in ejection fraction. However, 
there is a need for more randomized trials which investigate strain imaging as a closer 
predictor of depressed LV function. This study utilizes strain analysis to investigate the 






METHODS AND MATERIALS 
 
Ethical Considerations 
   Patient data was collected through the Society of Thoracic Surgeons database at Emory 
Hospital. A certificate through the Collaborative Institutional Training Initiative was 
obtained for “Biomedical Research Investigators and Key Personnel” by this investigator 
and submitted to the International Review Board before access to patient data was 
granted.   
Study Design 
   This is a retrospective subset of an interventional clinical trial with total estimated 
enrollment of 140 participants aged 18 years or older. The intervention-based portion of 
this study began March 20, 2018 and is projected to be completed by December 31, 2023. 
Patients were divided into three arms: UMA (Group 1), UMA+PMA (Group 2), and No 
Intervention (retrospectively identified patients who already underwent surgery at Emory 
Hospital). Retrospectively identified patients were suitable for the recruitment to this 
study for their post-operative investigation and were the core focus for the work done by 
this researcher.  
     The inclusion criteria for this study are as follows: patient has been diagnosed with 
FMR, left ventricular end diastolic diameter is less than or equal to 70mm, systolic 
tenting height is less than or equal to 12mm, mitral regurgitation is of moderate or greater 
severity (as defined by guidelines of American society of echocardiography at time of 





patient is able to sign informed consent and release medical information forms. The 
exclusion criteria are as follows: any evidence of structural (chordal or leaflet) mitral 
lesions, planned concomitant intra-operative procedures, planned concomitant intra-
operative Maze procedure for symptomatic paroxysmal atrial fibrillation, persistent atrial 
fibrillation, prior mitral valve repair, contraindication for cardiopulmonary bypass, 
clinical signs of cardiogenic shock at time or randomization, ST segment elevation 
myocardial infarction within 14 days prior to inclusion in this study, congenital heart 
disease (except PFO or ASD), chronic renal insufficiency, recent history of psychiatric 
disease likely to impair compliance with study protocol, and pregnancy at time of 
randomization.  
Surgical Technique 
  Participants who underwent UMA received a commercially available annuloplasty ring. 
In this procedure, 10-12 Ethicon sutures are placed around the mitral annulus and the 
metallic ring is then implanted on the annulus to reduce its size. An Edwards Lifesciences 
Physio II ring was used in all patients with ring size ranging from 26mm to 30mm. 
Patients who underwent the additional treatment of PMA received one or two 4-0 
pledgeted sutures used to draw the two papillary muscle tips together, reducing IPMS 
prior to UMA.   
Outcome Measures 
 The primary outcome measure of this study is the change in FMR severity, evaluated 
using cardiac echocardiography and/or MRI. Secondary outcome measures are organized 





Table 1: Secondary outcomes and corresponding time frames. 
Secondary Outcome Time Frame 
Mortality Rate Post-Intervention (Up to 20 Days), Post-
Intervention (Month 6), Post Intervention 
(Month 12) 
Number of Major Adverse Cardiac Events Duration of Study (6 Years) 
Change in Quality of Life Scale Score Baseline, Post-Intervention, Post-
Intervention (Month 12) 
Change in Minnesota Living with Heart 
Failure Questionnaire Score 
Baseline, Post-Intervention (Month 6), Post-
Intervention (Month 12) 
Change in Functional Status Assessed by 6-
Minute Walk Test 
Time Frame: Baseline, Post-intervention 
(Month 6), Post-Intervention (Month 12) 
All Cause Readmission Rate Post-Surgery (Up to 30 Days) 
Heart Failure Readmission Rate  Post-Surgery (Up to 30 Days) 
Change in Left Ventricular Volume Baseline, Post-Intervention (Month 6), Post-





Change in Left Ventricular Volume Baseline, Post-Intervention (Month 12) 
Change in Left Ventricular Mass Baseline, Post-Intervention (Month 6), Post-
Intervention (Month 12) 


























  MRIs from all patients were anonymized before evaluation in order to prevent bias. 
Segment Medviso software was then used to perform segmentation of the left ventricle 
from end-diastolic to end-systolic phases as is demonstrated by Figure 5. Trends in 
myocardial thickness were determined for basal, equatorial, and apical sections. All 










Figure 5: Apical slice demonstrating LV segmentation with 6 sectors, sector 1 being on the septal side.  
 
Using the end-diastolic point as the initial time frame for all slices, ventricular wall 






















Figures 6 (top left), Figure 7 (top right), Figure 8 (bottom left), and Figure 9 (bottom right): Sample 
of  data collected from a single representative basal slice in order to demonstrate the typical curves for wall 
thickness, fractional wall thickening, radial velocity, and radius. 
 
Strain Analysis 
  Myocardial strain analysis, conducted using the same Segment Medviso software, was 
used to measure the fractional change of myocardial dimension in specific directions. 
This is an established method used to assess myocardial function. In Figures 10-21, mean 
circumferential strain and mean radial strain are plotted for basal, equatorial, and apical 
regions. The peak mean radial strains and and peak mean circumferential strains for all 
patients was then compared and collected in Table 2.  For reference, the beginning time 



























































Figures 10-21: This group of figures (beginning with IMR 03 and ending with IMR19 in sequential order) 





segmented. Basal slices are shown in black, equatorial slices are shown in blue, and apical slices are shown 
in green. The general trends are evaluated in the discussion section.  
 
 




(Basal) IMR03 IMR05 IMR06 IMR07 IMR08 IMR10 
Peak Mean 
Circumferential Strain 
-13.2666 -12.101 -18.6094 -14.1607 -24.4615 -14.341 
Peak Mean Radial Strain 23.65743 24.80918 38.63005 34.05608 59.53872 22.53037 
  
 
     
(Equatorial)       
Peak Mean 
Circumferential Strain 
-11.6731 -14.0616 -19.8044 -10.7504 -32.7456 -20.6881 
Peak Mean Radial Strain 26.54165 24.7093 39.17755 24.54898 70.52113 42.2511 
        
(Apical)       
Peak Mean 
Circumferential Strain 
-8.37886 -13.3742 -28.0552 -12.3033 -36.0955 -25.116 
Peak Mean Radial Strain 21.00836 25.55984 32.03233 31.34163 59.70045 31.50744   
     
(Basal) IMR14 IMR15 IMR16 IMR17 IMR18 IMR19 
Peak Mean 
Circumferential Strain 
-15.1452 -15.4232 -14.7795 -21.0799 -18.567 -9.6659 
Peak Mean Radial Strain 18.27353 36.83629 28.00408 32.79171 30.841114 20.82769  
      
(Equatorial)       
Peak Mean 
Circumferential Strain 
-14.619 -16.766 -18.0114 -23.2761 -20.89 -7.7881 
Peak Mean Radial Strain 22.32571 39.14492 36.31635 42.24023 31.30918 9.52757  
      
(Apical)       
Peak Mean 
Circumferential Strain 
-9.34345 -22.2853 -28.8118 -24.8047 -15.1183 -8.5793 







Strain Analysis of LV 
   This project used computational methods to evaluate regional LV contractile function 
in ischemic mitral regurgitation (IMR). Strain measurement, defined as the change in 
length in a specific direction over the original length, was used to understand LV 
contractility. On the short-axis view of the LV, the myocardium thickens during systole, 
giving positive values for radial strains. This is contrasted by the shortening of the 
circumference of the LV myocardium during systole, which results in negative values for 
circumferential strains. The entire LV is broken down into basal, equatorial, and apical 
levels. At each level the myocardium is further divided into anterior, anteroseptal, 
inferolateral, inferior, inferolateral, and anterolateral pieces. The radial and 
circumferential strains were analyzed at all these locations in this report.  
    It should be noted that this retrospective clinical trial is still being conducted and 














      Future work on this project will include finishing the manual segmentation of MRIs 
for the remaining 54 patients and documenting primary and secondary outcome 
measures. Strain analysis will then be conducted with those patients as they were with the 
initial 12 in this paper. The final steps to investigating the hypotheses posed by this 
investigator will then include revealing the patients and their respective history of 
treatments and disease severity and analyzing both leaflet and ventricular geometry using 
echocardiography. Once a clear answer to these questions is obtained, surgeons will be 
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